Meet the Proteona team at the 11th AFOB Regional Symposium (ARS) conference in Singapore
Innovative genomic and proteomic analysis platform for Immuno-Oncology and Single Cell BioMedical Applications
Proteona announced that Dr Jonathan Scolnick will present at Asian Federation of Biotechnology (AFOB) Regional Symposium (ARS) conference in Singapore on the 24th January, 2019.
Dr Scolnick will share on Proteona's recent development on combining protein and gene expression to investigate the manufacturing of cell therapies.
For media queries, please contact:
Dr Andreas Schmidt
Proteona is a precision medicine company in Singapore, Germany, and the US that is pioneering the use of single cell multi-omics to improve clinical outcomes in cancer. Using a combination of innovative single cell assays and AI-assisted bioinformatics, Proteona enables pharmaceutical companies, biotech partners, and clinicians to integrate single cell level precision into their clinical projects. Proteona continues to develop comprehensive, disease-specific single cell databases combining gene expression, protein expression, and mutation information derived from each individual cells as well as drug response data for each sample. Proteona has been selected as a “One to Watch” by Nature Research Spinoff Award and a Winner of Falling Walls Ventures Breakthrough of the Year 2020. Proteona is a spin-off from the National University of Singapore (NUS) and the Agency for Science, Technology and Research (A*STAR).